BIOREGENX, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2022 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Bioregenx, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q1 2024.
- Bioregenx, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$68K, a 48.8% decline year-over-year.
- Bioregenx, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$484K, a 958% decline year-over-year.
- Bioregenx, Inc. annual Nonoperating Income (Expense) for 2023 was -$462K.
- Bioregenx, Inc. annual Nonoperating Income (Expense) for 2022 was $0.000, a 100% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)